Capital & Planning »

Diamedica Therapeutics shares owned by Capital & Planning

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Capital & Planning from 13F filings

Historical chart of Capital & Planning investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Capital & Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Capital & Planning

Quarter filed Position value Share count Share price at filing
2026-03-31 $14k 2.0k 6.77

More positions owned by Capital & Planning

Alphabet Common Stock (GOOGL)
Amazon Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Southern Company Common Stock (SO)
Visa Common Stock (V)
Eli Lilly Common Stock (LLY)
Duke Energy Common Stock (DUK)
Apple Common Stock (AAPL)
Mcdonalds Corp Common Stock (MCD)
Caterpillar Common Stock (CAT)
Church & Dwight Common Stock (CHD)
Nvidia Corp Common Stock (NVDA)
Procter & Gamble Common Stock (PG)
Texas Instruments Common Stock (TXN)
Meta Platforms Common Stock (META)

View all positions for Capital & Planning

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
State Street Corporation
First Manhattan
Bleichroeder
Vanguard Capital Management
Northern Trust
Advisor Group Holdings
LPL Financial
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Diamedica Therapeutics